️Panel Discussion: Searching for the ‘Crystal Ball of Dermatology’: Disease Modification
Time: 2:00 pm
day: Day One
Details:
- What progress has the industry made in shifting from symptom management to truly modifying disease pathways in conditions like Atopic Dermatitis, Hidradenitis Suppurativa, Vitiligo, and Pruritis?
- What are the key biological targets and mechanisms that show the most promise for delaying, slowing, or reversing disease progression in immunodermatology?
- What lessons can be learned from other therapeutic areas that have successfully developed disease-modifying treatments, and how can they be applied to dermatology?
- What impact would disease-modifying treatments have on the existing dermatology landscape?
